Expression of VP16-CREB, a constitutively active form of CREB, in hippocampal neurons of the CA1 region lowers the threshold for eliciting the late, persistent phase of long-term potentiation (L-LTP) in the Schaffer collateral pathway. This VP16-CREB-mediated L-LTP differs from the conventional late phase of LTP in not being dependent on new transcription. This finding suggests that in the transgenic mice the mRNA transcript(s) encoding the protein(s) necessary for this form of L-LTP might already be present in CA1 neurons in the basal condition. We used highdensity oligonucleotide arrays to identify the mRNAs differentially expressed in the hippocampus of transgenic and wild-type mice. We then explored the contribution of the most prominent candidate genes revealed by our screening, namely prodynorphin, BDNF, and MHC class I molecules, to the facilitated LTP of VP16-CREB mice. We found that the overexpression of brain-derived neurotrophic factor accounts for an important component of this phenotype.
Introduction
The encoding of new memories in the brain is thought to depend on long-lasting changes in the strength of *Correspondence: abarco@umh.es 7 These authors contributed equally to this work. 8 synaptic connections between neurons, a change that depends, in turn, on transient or permanent alterations in specific patterns of gene expression. A number of transcription factors have been identified that play important roles during learning-related synaptic plasticity. Of these, the best-studied factor is the cAMP-responsive element binding protein CREB (reviewed in Barco et al., 2003; Lonze and Ginty, 2002) . There is increased phosphorylation of CREB following stimuli that produce memory-related long-term potentiation (LTP) (Bito et al., 1996) as well as after training on hippocampusdependent tasks (Taubenfeld et al., 1999) . Similarly, the late phase of LTP and long-term memory storage correlate with increased cAMP responsive element (CRE)-dependent gene expression, as monitored via the activity of a CRE-driven lacZ reporter construct in transgenic mice (Impey et al., 1996 (Impey et al., , 1998 .
To explore the role of CRE-driven genes in hippocampal synaptic plasticity, we generated transgenic mice in which we could induce, in a regulated manner and restricted to forebrain neurons, the expression of VP16-CREB, a constitutively active CREB protein. In the pyramidal cells of the CA1 region, the postsynaptic neurons of the Schaffer collateral pathway, VP16-CREB binds to CRE sites, regulates transcription of a number of CREB-dependent genes, and facilitates the establishment of L-LTP in a transcription-independent way. Based on these results we proposed a model in which VP16-CREB activates the transcription of CRE-driven genes and leads to a cell-wide distribution of proteins or mRNAs that prime synapses so that even a relatively weak stimulus will give rise to a long-lasting form of LTP (Barco et al., 2002) .
To identify gene products upregulated in VP16-CREB mice that are responsible for the rapid consolidation of the long-term process following even a relatively weak stimulus, we carried out an analysis of altered gene expression in the hippocampus of these mice by using Affymetrix high-density oligonucleotide arrays. We identified mRNA transcripts differentially expressed in the hippocampus of transgenic and wild-type mice and then combined pharmacological and genetic approaches to investigate the possible contributions of the most prominent candidate genes in facilitating the L-LTP in the Schaffer collateral pathway of VP16-CREB mice.
Results and Discussion

Identification of Genes Whose Altered Expression in the Hippocampus of VP16-CREB Mice Correlates with the Facilitated L-LTP in the Schaffer Collateral Pathway
To better characterize the facilitated L-LTP phenotype of VP16-CREB mice, we carried out a time course analysis of the onset and reversion of this phenotype. We found that it was possible to switch transgene expression on and off in the hippocampus of mutant mice over the course of a week by controlling the presence of doxycycline (dox) in the animals' diet and at the we used 81 transgenics and 26 wild-type mice divided into 12 different groups (in average, nine mice per group). The final data set included gene chips for animals on dox; 1, 2, 3 (microdissected CA1 regions), and 5 weeks after doxycycline removal; mice that expressed VP16-CREB for 3 weeks before turning transgene off again for 2 weeks (rev), and wild-type littermates (WT, n = 1 because one of the samples from whole hippocampus and the sample from microdissected CA1 regions were used as baseline). (C) Two-dimensional hierarchical clustering of ten samples and 73 genes, selected to include only those genes that were consistently changed in VP16-CREB mice after transgene induction but were unaltered in the different control situations (WT, DOX, and REV). See filter details in Table 1 legend. Two samples corresponding to wild-type mice (obtained from whole hippocampi or microdissected CA1 regions, respectively) were used for normalization and could not be included in this clustering. same time that it was possible to regulate the LTP phenotype ( Figure 1A) .
To identify the specific genes whose induction in hippocampal neurons correlated with the facilitated L-LTP phenotype, we harvested hippocampal mRNA at time points assessed in our physiological study and carried out a gene expression analysis with the use of oligonucleotide microarrays. To obtain a sufficient quantity of poly(A)-RNA and reduce the effect of the biological variability of the sample, hippocampi from six to ten mice matched for genotype and time of induction were pooled together in each sample. The final data set included gene chips for animals on dox (gene Off) and for animals that had been removed from dox (gene ON) for 1, 2, and 5 weeks. We also included samples from wild-type mice maintained under identical conditions and from transgenic mice that expressed VP16-CREB for 3 weeks before turning the transgene off again for 2 weeks with dox (Rev, gene Off). Because the isolation of mRNA from the whole hippocampus favors genes that are more broadly overexpressed in the hippocampus of transgenic mice and, therefore, may lead to an underestimation of the total complement of genes showing an altered expression in specific hippocampal subregions, we extended our comparison between transgenic and wild-type expression profiles by using microdissected CA1 regions. We obtained two samples corresponding to VP16-CREB mice 3 weeks after induction and one sample corresponding to wild-type mice kept in the same conditions. These mRNA samples were analyzed with Affymetrix gene chips MG-U74v2 setA, which allow the simultaneous analysis of 12,654 probe sets representing fulllength mouse genes and Expressed Sequence Tag (EST) clusters from the UniGene database (Build 74). We filtered and sorted the data through several sequential analyses by using the GCOS software package from Affymetrix. The change p value algorithm provides a measure of the likelihood of change and direction and is used to generate discrete change calls: I (increase), MI (marginal increase), NC (no change), D (decrease), and MD (marginal decrease). In our analysis, we demanded that the change call for all of those samples in which VP16-CREB expression was turned on (seven samples) indicated a statistically significant change in expression (i.e., I, MI, D, or MD). In addition, we also requested that the change call for wild-type samples or for those samples in which VP16-CREB expression was turned off was NC. Using this procedure, a surprisingly small list of only four genes emerged ( Figure 1B and Table 1 , first four rows). Notably, among these candidates was CREB itself, two well-known CREB-dependent genes (dynorphin and BDNF), and one MHC class I antigen.
We sorted these candidate genes using the signal log ratio (SLR), which estimates the magnitude and direction of the change. SLR values are expressed as the log2 ratio of the change in expression level between a baseline and an experiment array. First on our list, with the largest change, 13-fold on average, was the probe set targeted to prodynorphin, a gene that we had previously identified as being upregulated in VP16-CREB mice (Barco et al., 2002) . In second place, we found a probe set targeted to CREB that recognizes a sequence present in both endogenous CREB and chimeric VP16-CREB mRNAs. Because the analysis of protein extracts from transgenic mice did not show any apparent change in the level of expression of endogenous CREB (Barco et al., 2002) , the upregulation detected by the CREB probe likely corresponds to the induction of VP16-CREB transcripts. We cannot however exclude some contribution of the endogenous CREB transcripts, because the CREB promoter contains three CRE sites that confer positive cis-autoregulation. The presence of the CREB probe set in this restricted list of altered genes represented a valuable control that validated our analysis. The third probe set in our list recognizes transcripts encoding an isoform of MHC class I antigen. Class I MHC molecules are encoded by a large and highly homologous gene family whose role in regulating the immune response is well known and that has more recently also been found to be involved in synaptic plasticity (reviewed in Boulanger and Shatz, 2004) . Finally, at the bottom of our list was BDNF. Although the change in BDNF mRNA was relatively small, it paralleled VP16-CREB expression in all of our samples.
Our initial highly restrictive criterion was designed to identify a small number of VP16-CREB target genes. By using a less restrictive criterion for sorting the data, we obtained a larger list of genes affected by the induction of VP16-CREB (Table 1 ). The hierarchical clustering of these probe sets revealed a good correlation between the altered expression of candidate genes and time after transgene induction. The clustering also highlighted the similarity of the expression profiles of samples from whole hippocampi and microdissected CA1 regions ( Figure 1C ). The extended list of candidate genes included a number of genes related to neuronal function and metabolism, such as c-fos, calcyclin, the vesicular GABA and glycine transporter, and neuropeptide Y. It is possible that additional genes that are differentially regulated in VP16-CREB mice escaped our screen because the microarray MG-U74A does not interrogate the complete mouse genome.
In a given cell, only a subset of the CRE sites in its genome is readily available for the binding of CREB and other CRE binding transcription factors, although the transactivation activity of bound CREB will remain low until the cell is exposed to extracellular stimuli that trigger its phosphorylation and the recruitment to the promoter of its coactivator CBP (Lonze and Ginty, 2002 It is also possible that some of the genes detected in our analysis are indirect targets of CREB. The identification of several transcription factors that are upregulated in VP16-CREB mice, including the immediate early response genes (IEG) c-fos, a well-known gene induced by neuronal activity, suggests that there may exist a second wave of transcriptional activation triggered by VP16-CREB induction. Notably, Table 1 also contains more than a dozen probes targeted to MHC class I antigen sequences, both classical and nonclassical. In addition to MHC class I antigens, we also found that other genes related to immune and inflammatory response were upregulated during the course of our experiment. It is difficult, however, to know whether the induction of these genes is a direct consequence of the activity of VP16-CREB or a side effect of the upregulation of MHC I observed at early time points. We are currently investigating the long-term consequences of this altered expression on neuronal survival.
Validation of Gene Chip Results by In Situ Hybridization
We used in situ hybridization to assess the expression of a number of interesting candidate and control genes. ( These experiments revealed an interesting feature of VP16-CREB-dependent gene expression: the response of different brain regions to the induction of constitutively active CREB protein was different. For some genes, such as those encoding MHC I antigens, the regional pattern of expression closely mirrored that of VP16-CREB, whereas for others the altered expression was restricted to a subset of cells. Thus, in the case of prodynorphin, the response in striatal neurons was amplified in comparison to hippocampal neurons, consistently with the natural pattern of expression of this gene, higher in striatum than in hippocampus, whereas IEGs, such as BDNF, c-fos, or junB, were highly expressed exclusively in the CA1 region of the hippocampus. These results suggest the contribution of epigenetic mechanisms, such as cell type-specific methylation of CRE sites, and region-specific transcription factors working together with CREB on the transcriptional regulation of these genes.
Functional Validation of Candidate Genes
We next combined pharmacological and genetic approaches to investigate the role of the three most prominent candidate genes (dynorphin, MHC I, and BDNF) in the enhanced form of L-LTP observed in VP16-CREB transgenic mice.
Prodynorphin Is Highly Overexpressed in CA1 Cells of VP16-CREB Mice but Is Not Required for the Enhanced L-LTP Phenotype
The gene Pdyn encodes prodynorphin, the precursor of several biologically active opioid peptides known as dynorphins. Although the role of prodynorphin in controlling pain and responses to stress in the peripheral nervous system has been studied extensively, its role in the central nervous system, including its possible role in learning and memory, is less understood. Two different modes of action have been suggested for dynorphins, one dependent on opioid receptors that is blocked by the antagonist naloxone, the other dependent on a nonopioid receptor that is resistant to naloxone and blocked by NMDA antagonists (Shukla and Lemaire, 1994). In the granular neurons of the dentate gyrus, dynorphin plays an inhibitory role in synaptic plasticity of the mossy fiber (Terman et al., 1994; Wagner et al., 1993). However, in the Schaffer collaterals terminating in the CA1 region, where κ-opioid receptors are absent, dynorphin appears to have dual effects on NMDA synaptic currents, increasing NMDA currents at low concentrations of dynorphin and decreasing these currents at high concentrations (Caudle et al., 1994) .
To explore further the general role of dynorphin in hippocampal LTP in the Schaffer collateral pathway, we first tested the effect of bath-applied dynorphin (1-13) [Dyn(1-13)], a biologically active form of this neuropeptide. We found that Dyn(1-13) did not affect basal synaptic transmission ( Figure 3A ; 10 min before incubation, (Figures 3A and 3B ; 1-20 min, percent baseline = 189% ± 17.8% for control and 194% ± 17.6% for Dyn(1-13), p = 0.39; 100-115 min, percent baseline = 103% ± 2.2% for control and 105.8% ± 3% for Dyn(1-13), p = 0.11). There was however a transient increase in the amplitude of LTP after the peptide was removed from the bathing solution (30-60 min, percent baseline = 135% ± 10% for control and 156% ± 12.5% for Dyn(1-13), p = 0.034).
To carry this investigation further, we examined the consequences of depleting dynorphin. Pdyn knockout mice (Pdyn −/− ) are viable and show no apparent phenotypic alterations (Sharifi et al., 2001 ). We first tested whether basal synaptic plasticity in the Schaffer collateral pathway was affected in these mutants and found that the stimulus-response curve was similar in wildtype and knockout mice ( Figure 3C , p = 0.39). Longterm depression (LTD) as well as both E-LTP and L-LTP, induced, respectively, by 1 Hz stimulation, one train of 100 Hz, or by four trains of 100 Hz stimulation, were also unaltered by the dynorphin deficiency ( Figure 3D , LTD 60-90 min, percent baseline = 85% ± 4.79% for wild-type and 86% ± 4.22% for Pdyn −/− ; p = 0.11; Figure  3E , E-LTP 30-60 min, percent baseline = 123% ± 7.1% for wild-type and 130% ± 6.2% for Pdyn −/− ; p = 0.12; and Figure 3F , L-LTP 90-120 min, percent baseline = 171% ± 7.6% for wild-type and 180% ± 5.8% for Pdyn −/− ; p = 0.07). Dynorphin therefore does not appear to play a relevant role in these forms of synaptic plasticity in wild-type animals.
We next tested the consequences of dynorphin de- pletion in VP16-CREB mice by crossing VP16-CREB mice with mice deficient in dynorphin expression. In the hippocampus of wild-type mice, the expression of dynorphin peptides is low in the granular cells of dentate gyrus and undetectable in CA1 and CA3 regions, whereas the staining of sections from VP16-CREB mice revealed that the same CA1 neurons that expressed VP16-CREB in the nucleus also overexpressed dynorphin in the cytoplasm (data not shown). As expected, To identify the MHC I variants expressed in the hippocampus of VP16-CREB mice, we performed RT-PCR of hippocampal mRNA by using primers targeted to a segment that varies considerably among different class members of the MHC I antigen family (see Table S1 in the Supplemental Data available online). We found that both wild-type and transgenic mice expressed multiple MHC I antigens in hippocampal neurons, although the level of expression for the different MHC I subfamilies, both classical and nonclassical, was higher in mutant mice ( Figure 4A and data not shown) .
Figure 3. The Exogenous Addition or the Genetic Suppression of Dynorphin Does Not Affect Normal L-LTP nor Facilitated L-LTP in VP16-CREB Mice Exogenous addition of dynorphin (250 nM) had no significant effect either on test fEPSPs generated at CA3-CA1 synapses of wild-type mice (A) or in the duration of E-LTP induced by a single tetanus of 100 Hz stimulation (B). (C) Input-output curve of fEPSP slope (mV/ms) versus stimulus (V) at the Schaffer collateral pathway of hippocampal slices from Pdyn
As a first step in exploring the possible contribution of alterations in MHC I to the facilitated L-LTP observed in VP16-CREB mice, we analyzed the response to 100 Hz stimulation in the Schaffer collateral pathway of CD3δ Figure 5A ). We found that the expression of mRNAs bearing exons 1, 2, and 3 were significantly increased in VP16-CREB mice whereas the expression of exons 4 and 5 were not affected ( Figure  5B ). Interestingly, exons 1, 2, and 3 are clustered within 1.5 kb at the 5# end of the gene and 15 kb apart from exons 4 and 5. The analysis of the genomic sequence upstream of exon 1 has revealed the existence of regulatory elements responsible for the Ca 2+ -mediated activation of PI (Tabuchi et al., 2000) , including a CRE site that overlaps with a USF binding element (Tabuchi et  al., 2002) . CRE elements have also been reported upstream of PII, although their functionality has not been confirmed (Hayes et al., 1997) . Previous studies on the rat BDNF gene suggested that the promoters PI and PII shared common regulatory elements. Indeed, a neuralrestrictive silencer element (NRSE) located in intron 1 contributes to the regulation of both promoters (Timmusk et al., 1999) . Because the molecular interactions that underlie the activation of transcription by VP16-CREB and phospho-CREB are different, the transactivation driven by the VP16 domain might have a broader range than that of CREB. It is therefore possible that the binding of VP16-CREB to the CRE element in PI also activates the expression driven by promoter PII and even PIII, which are located relatively close downstream of a functional CRE site but have not been previously reported as being regulated by CREB. Strikingly, we did not detect any effect of VP16-CREB expression on the expression of BDNF driven by promoter PIV, in spite of the presence of a conserved CRE site upstream of this promoter (Shieh and Ghosh, 1999; Tao et al., 1998). Experiments in rat neuronal cultures have found that membrane depolarization induces the transcription from both P1 and PIII (PIV in the mouse). Some of these experiments suggest that PIII responds to depolarization but not to an increase of internal cAMP (Tao et al., 2002) , suggesting that the activation of CREB is not sufficient to drive rat BDNF PIII expression, a view that might explain our negative results for mouse promoter PIV.
To evaluate the component of the facilitated L-LTP in VP16-CREB mice that is due to an enhanced expres- To further explore the role of BDNF in synaptic capture, we used mice in which the genetic deletion was restricted either to the entire forebrain, including both the CA3 and CA1 pyramidal neurons of the hippocampus, or only to the postsynaptic CA1 neurons. Thus, we could assess the individual contributions of pre-and postsynaptic sources of BDNF. We found that both types of BDNF mutants had normal 4 × 100 Hz-induced L-LTP in S1 but exhibited a defect in synaptic capture in S2 (Figures 7B and 7C . We designated as VP16-CREB mice those bitransgenic animals that resulted from the crossing of pCaMKII-tTA (line B) and tetO-VP16-CREB (line VC27) mice. In experiments using VP16-CREB mice, dox was administrated at 40 mg/Kg of food and was removed at specific times before experimentation. Mice were maintained and bred under standard conditions, consistent with NIH guidelines and approved by the IACUC.
Microarrays
Total RNA was extracted from dissected hippocampi or microdissected CA1 regions using TRIzol (Invitrogen) according to the manufacturer's protocol. PolyA mRNA was then isolated using Messagemaker kit (Pharmacia). cDNA synthesis and cRNA production and fragmentation were carried out as described in the Expression Analysis Technical Manual (Affymetrix). U74Av2 gene chips were hybridized, stained, washed, and screened for quality according to the manufacturer's protocol. The Affymetrix gene chip data were processed, normalized, and statistically analyzed using GCOS 1.2 software. The TGT value chosen for the normalization was 500, and each array was normalized according to its baseline (mRNA from the hippocampus or microdissected CA1 regions of wild-type littermates). The scaling factor after normalization was comparable in all arrays. I, D, MI, MD, and NC calls where obtained according to the change threshold defined by the software. We filtered and sorted the list of genes using the change p value, change call, and log ratio signal as described in the text and figure legends. Subsequent agglomerative hierarchical clustering analysis was performed using the Spotfire DecisionSite for Functional Genomics software (Somerville, MA). We used the UPGMA (unweighted average) clustering method and based the measure of similarity on euclidean distances. Function annotations in Table 1 were generated using the gene ontology browser tool included in the SpotFire software and the ontology information available in NetAffx analysis center.
In Situ Hybridization and Quantitative RT-PCR Radioactive in situ hybridization was performed as described in Wisden and Morris (1994) with [ 33 P]ATP-labeled oligonucleotides. MHC I transcripts were also detected using DIG-labeled RNA probes and a Tyramide signal amplification kit (Molecular Probes, Eugene, OR). qPCR was carried out in an Applied Biosystems 7300 real-time PCR unit using the SYBR Premix ex Taq mix (Takara) and primers specific for the different BDNF exons (Table S2) . Each independent sample was assayed in triplicate and BDNF levels were normalized using GAPDH.
